scispace - formally typeset
I

Ina Oehme

Researcher at German Cancer Research Center

Publications -  83
Citations -  10447

Ina Oehme is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Histone deacetylase & Medicine. The author has an hindex of 29, co-authored 58 publications receiving 8441 citations. Previous affiliations of Ina Oehme include University of Freiburg & University Hospital Heidelberg.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

HDAC family: What are the cancer relevant targets?

Olaf Witt, +7 more
- 08 May 2009 - 
TL;DR: Individual HDAC family members as drug targets in cancer are discussed taking into consideration their function under physiological conditions and their oncogenic potential in malignant disease.
Journal ArticleDOI

Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

Ina Oehme, +11 more
- 01 Jan 2009 - 
TL;DR: The data point toward an important role of HDAC8 in neuroblastoma pathogenesis and identify this HDAC family member as a specific drug target for the differentiation therapy of neuroblastomas.
Journal ArticleDOI

DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.

David Brocks, +35 more
- 01 Jul 2017 - 
TL;DR: By mapping global transcription start site (TSS) and chromatin dynamics, this work observed the cryptic transcription of thousands of treatment-induced non-annotated TSSs (TINATs) following DNMTi and HDACi treatment.